Elasty D Plus

Key Features of Elasty D Plus:

Elasty D Plus: HA Filler for Wrinkles & Lip Enhancement

Elasty D Plus is a highly popular choice in the market, and it is especially valued for its cost-effectiveness. It is designed for deep wrinkles, lip augmentation and restoring volume to sunken areas like cheeks, chin, and jawline.

It uses advanced cross-linked hyaluronic acid, ensuring excellent hydration and elasticity. The product’s unique Preserved Natural Entanglement Technology (PNET) enhances its gel structure, providing long-lasting and natural-looking results.

This dermal filler also contain lidocaine, which reduces pain during application, ensuring a comfortable experience. With its ability to improve skin texture and retain moisture, Elasty D Plus is a popular choice for anti-aging treatments.

Benefits of Elasty D Plus:

• Elasty D Plus is highly purified, minimizing the risk of allergic reactions.
• This filler features cross-linked HA fibers for long-lasting effects.
• Elasty D Plus contains lidocaine, ensuring a comfortable and painless procedure.
• The product resists biodegradation, providing extended durability.
• Elasty D Plus is ideal for thin skin and sensitive areas, offering gentle yet effective treatment.
• This injectable is perfect for filling deep wrinkles, lip augmentation and folds with reliable results.

Application area:

Elasty D Plus is ideal for:

• Correcting deep wrinkles around the mouth and nose.
• Smoothing forehead wrinkles.
• Treating perioral wrinkles.
• Shaping the nose and cheeks.
• Lip augmentation

Mechanism of Action: PNET™ Technology

Elasty’s PNET™ stabilizes by focusing on two key principles:

1. Minimal BDDE Cross-Linking: The technology uses a minimum amount of the cross-linking agent BDDE (1,4-butanediol diglycidyl ether) to create a cohesive and elastic gel structure.
2. Advanced Purification: The manufacturing process includes multiple washing steps designed to remove residual and inactive BDDE. Manufacturer-facing technical materials for the Elasty platform report a monophasic gel with residual BDDE content below 0.2 ppm, a level well within established regulatory safety thresholds.

This process yields a filler intended to provide durable correction while maintaining a safety profile aligned with industry best practices for residual crosslinker levels.